Cost-Effectiveness Analysis (CEA) of Linezolid Versus Vancomycin in the Treatment of Nosocomial Pneumonia Caused by Methicillin-Resistant Staphylococcus Aureus (MRSA-NP) Based on a Phase IV Clinical Trial: Results from Four Major Cities in China

✍ Scribed by Wan, Y.; Wang, X.; Wu, B.; Kang, H.; Li, Q.; Chen, Y.; Li, J.Z.; Liu, S.; Gao, X.

• Book ID: 122271428
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 61 KB
• Volume: 16
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2013.08.209